Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study

Kristine Løssl, Anne Loft, Nina L C Freiesleben, Susanne Bangsbøll, Claus Yding Andersen, Anette T Pedersen, Dorthe Hartwell, Anders Nyboe Andersen

    42 Citationer (Scopus)

    Abstract

    The key enzyme in the biosynthesis of estradiol, aromatase, has been demonstrated within endometriosis. Combined administration of aromatase inhibitor and GnRH-agonist may efficiently suppress estrogen biosynthesis through a combined pituitary, ovarian, peripheral and "in situ" action. The aim of this study was to test the concept of combined down-regulation prior to IVF in patients with endometriomas.
    OriginalsprogEngelsk
    TidsskriftEuropean journal of obstetrics, gynecology, and reproductive biology
    Vol/bind144
    Udgave nummer1
    Sider (fra-til)48-53
    Antal sider6
    DOI
    StatusUdgivet - 1 maj 2009

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study'. Sammen danner de et unikt fingeraftryk.

    Citationsformater